Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.393T
Market Weight
11.16%
Industries
11
Companies
1203
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.84%
S&P 500
0.46%

YTD Return

Sector
1.00%
S&P 500
5.84%

1-Year Return

Sector
2.10%
S&P 500
22.03%

3-Year Return

Sector
2.18%
S&P 500
20.77%

5-Year Return

Sector
63.05%
S&P 500
72.53%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightDay ReturnYTD Return
All Industries 100% -0.84% 1.00%
Drug Manufacturers - General 33.83% -1.03% 5.80%
Healthcare Plans 13.57% 0.49% -4.46%
Medical Devices 13.13% -0.56% 4.35%
Diagnostics & Research 11.49% -1.62% 1.53%
Biotechnology 10.90% -1.59% -10.28%
Medical Instruments & Supplies 6.65% -1.06% 1.47%
Medical Care Facilities 2.91% -1.43% 8.29%
Drug Manufacturers - Specialty & Generic 2.68% -0.08% -9.57%
Medical Distribution 2.47% 0.50% 11.30%
Health Information Services 2.14% -0.90% 6.28%
Pharmaceutical Retailers 0.24% -1.17% -32.33%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Largest Companies in This Sector

Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
724.87 826.94 10.97% 689.182B -1.00% +24.35%
Buy
493.86 566.61 7.23% 454.391B +1.35% -6.19%
Buy
146.82 173.75 5.63% 353.804B -1.15% -6.33%
Buy
130.72 137.78 5.27% 331.118B +2.93% +19.90%
Buy
167.29 184.70 4.72% 296.212B -0.30% +7.95%
Buy
571.73 613.15 3.47% 218.237B -0.98% +7.71%
Buy
106.86 126.69 2.95% 185.421B -0.03% -2.92%
Buy
245.80 270.66 2.90% 182.061B -1.84% +6.25%
Buy
269.38 306.20 2.30% 144.489B -1.33% -6.47%
Buy
25.26 31.10 2.28% 143.036B -3.84% -12.26%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
139.92 41.319B 0.09% +2.60%
255.24 21.195B 0.10% +1.81%
125.67 7.632B 0.45% -7.49%
82.22 7.551B 0.35% -7.92%
55.27 5.76B 0.40% +2.41%

Mutual Fund Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
205.62 47.432B 0.29% -1.67%
86.70 47.432B 0.29% -1.67%
128.65 21.195B 0.10% +2.58%
90.02 15.399B 0.80% +2.41%
90.27 14.712B 0.80% +2.44%

Healthcare Research

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Merck & Co., Inc.

    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

    Rating
    Price Target
     
  • Analyst Report: Bristol-Myers Squibb Company

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

    Rating
    Price Target
     
  • Analyst Report: Laboratory Corporation of America Holdings

    Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

    Rating
    Price Target
     
  • Analyst Report: Intuitive Surgical Inc

    Intuitive Surgical designs, manufactures, and markets da Vinci robotic surgical systems, and related instruments and accessories in the U.S. and internationally. The da Vinci system enables surgeons to perform a wide range of surgical procedures with shorter recovery periods and higher patient comfort. ISRG was founded in 1995 and is headquartered in Sunnyvale, California.

    Rating
    Price Target
     

From the Community

Healthcare News